Amneal Pharmaceuticals (AMRX) EPS (Basic) (2018 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly EPS (Basic) of $0.25 for Q1 2026, up 211.86% year-over-year from $0.08 in Q1 2025, and up 56.02% quarter-over-quarter from $0.16 in Q4 2025.
Amneal Pharmaceuticals (AMRX) EPS (Basic) (2018 - 2026) Analysis & Trends
Amneal Pharmaceuticals' EPS (Basic) history runs 9 years deep, the most recent figure standing at $0.25 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 211.86% year-over-year to $0.25; the TTM figure through Mar 2026 stood at $0.57 (up 450.48% YoY), while the FY2025 annual figure was $0.41, up 207.92% from the prior year.
- EPS (Basic) for Q1 2026 stood at $0.25, up from $0.16 in the prior quarter.
- The five-year high for EPS (Basic) was $0.25 in Q1 2026, with the low at -$0.8 in Q2 2022.
- The 5-year median for EPS (Basic) is $0.04 (2024), against an average of -$0.05.
- Peak annual rise in EPS (Basic) reached 453.46% in 2023, while the deepest fall reached 1851.06% in 2023.
- Amneal Pharmaceuticals' EPS (Basic) stood at -$0.03 in 2022, then tumbled by 1851.06% to -$0.56 in 2023, then surged by 88.01% to -$0.07 in 2024, then surged by 335.65% to $0.16 in 2025, then soared by 56.02% to $0.25 in 2026.
- Business Quant data shows AMRX's EPS (Basic) at $0.25 in Q1 2026, $0.16 in Q4 2025, and $0.06 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 0.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.22 |
| Mar 31, 2026 | 0.25 |
| Dec 31, 2025 | 0.16 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | 0.11 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | -0.07 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.05 |
| Mar 31, 2024 | -0.27 |
| Dec 31, 2023 | -0.56 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | -0.05 |
| Dec 31, 2022 | -0.03 |
| Sep 30, 2022 | -0.02 |
| Jun 30, 2022 | -0.80 |
| Mar 31, 2022 | -0.01 |
| Dec 31, 2021 | -0.04 |
| Sep 30, 2021 | -0.03 |